Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis.
Acid-sensing ion channels in pathological conditions.
Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.
Coexistence of peripheral myelin protein 22 and dystrophin mutations in a Chinese boy.
Radiolabeling and in vitro / in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
Homing frequency of human T cells inferred from peripheral blood depletion kinetics after sphingosine-1-phosphate receptor blockade.
Management of fingolimod-associated macular edema.
Lack of association between AQP4 polymorphisms and risk of inflammatory demyelinating disease in a Korean population.
Transplantable living scaffolds comprised of micro-tissue engineered aligned astrocyte networks to facilitate central nervous system regeneration.
Efficacy and safety of beta-interferon in Thai patients with demyelinating diseases.
Proteomics comparison of the sera from multiple sclerosis patients and neuromyelitis optica patients.
Statins as immunomodulators: comparison with interferon-beta 1b in MS.
Exosomes in neurologic and psychiatric disorders.
New data identify an increasing sex ratio of multiple sclerosis in Sweden.
Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis.
Obtaining from Grape Pomace an Enzymatic Extract with Anti-inflammatory Properties.
Acid Sphingomyelinase-Derived Ceramide Regulates ICAM-1 Function during T Cell Transmigration across Brain Endothelial Cells.
Early onset (childhood) monogenic neuropathies.
Endogenous GABA controls oligodendrocyte lineage cell number, myelination, and CNS internode length.
[Neurodegeneration in multiple sclerosis and the neuroprotective effect of glatiramer acetate: a literature review].
Walking Performance: Correlation between Energy Cost of Walking and Walking Participation. New Statistical Approach Concerning Outcome Measurement.
Oligodendroglia and neurotrophic factors in neurodegeneration.
The over time development of chronic illness self-management patterns: a longitudinal qualitative study.
A prospective cohort study of vitamin D in optic neuritis recovery.
Aquaporins, anti-aquaporin-4 autoantibodies and neuromyelitis optica.
Pages
« first
‹ previous
…
348
349
350
351
352
353
354
355
356
…
next ›
last »